Life science and biotechnology ecosystem 

Mainz is an impressive location, offering excellent educational and research facilities as well as strong players in the life sciences and biotechnology industry.

Find out about Mainz, its commitment to life sciences and biotechnology, and the people involved!


Mainz is a life science and biotechnology hub with a diversified and powerful ecosystem. Mainz and the surrounding region are in excellent shape, boasting strong players and major companies from the life sciences and biotechnology industry (such as Boehringer Ingelheim, Merck, Sanofi, BioNTech and Schott). Other life science and biotechnology companies, as well as suppliers, are also located in the vicinity and contribute significantly to the growth of the industry.

Tuition Icon

Educational and research facilities create a sound knowledge base and make a significant contribution to economic prosperity. Nine partnership-focused research facilities, eight hospitals and two universities with a first-class reputation drive interdisciplinary research in the field of life sciences and related research and special research fields in the area.

Two of seven finalists in the second round of the Clusters4Future competition funded by the German Federal Ministry of Education and Research — the Cluster for Atherothrombosis and Individualized Medicine (curATime) initiative and the Electrifying Technical Organic Syntheses (ETOS) network — are based in Mainz and play a major role, demonstrating the excellent work of local researchers and their outstanding connections to each other.

The Cluster for Individualized Immune Intervention (Ci3 e. V.) is another active network that pools existing immunotherapeutic and diagnostic expertise in the Rhine-Main region in the development of new prevention, treatment and diagnostics options.

The Mainz Research Alliance has represented the broad-based, high-standard research and technological expertise in and around Mainz since 2008.

The Association for Cancer Immunotherapy (CIMT) is a member-based organization that facilitates the knowledge exchange between academic and industry scientists, physicians and regulatory authorities who research and develop cancer immunotherapies. Every year, the CIMT organizes the largest and most influential international cancer immunotherapy meeting in Europe.

With almost 40,000 students enrolled at Johannes Gutenberg University and the University of Applied Sciences, Mainz is one of the most popular university cities in Germany, creating an attractive skilled labor market where companies can establish contacts with students from an early stage.


Local economic development

Mainz is pursuing an ambitious vision of heavily expanding life sciences and biotechnology in the area over the coming years that includes investments in the construction of modern buildings, laboratories, offices and housing. In addition, a campus area is being developed to connect the various stakeholders. This area is well connected, and several residential areas will be built in the surrounding area. Thanks to the recent boom in the biotechnology industry, the city of Mainz is in a position to offer competitive trade tax rates, which further boosts the appeal of the location for companies and start-ups.

The plan is to actively strengthen and expand the existing network. For all participants involved, this is a unique opportunity to actively shape the development of the local economy and get involved in creating a life science and biotechnology cluster right from the outset.


Development of the site near the two universities has already begun. 
Photo: Lukas Görlach

Platform Biotech & Life Sciences

On behalf of the state capital Mainz, we support the establishment of an internationally recognized biotechnology & life science platform in Rhineland-Palatinate.

Biotechnology is a highly dynamic field of research. There is great potential when different disciplines work together, and research and industry form a network.

To strengthen activities, the state government of Rhineland-Palatinate is setting up a new platform for biotechnology and life sciences in close cooperation with the state capital Mainz.

PK Plattform RLP

In the photo from left to right: Minister of Economics Daniela Schmitt, Minister President Malu Dreyer and the Lord Mayor of Mainz Nino Haase.

With the development of the state-wide platform and close networking of the biotechnology players, existing companies are consolidated, spin-offs are accelerated and the business and innovation location is strengthened overall.

More information can be found here.

Jan Uphoff

»Any questions? We are happy to help!«

Jan Uphoff


Evelyn Rossmann

Dr. Evelyn Rossmann